Modulus Discovery, Inc.
10:30 AM - 10:45 AM (EDT), Thursday, June 8, 2023 ・ Session Room 103
Modulus Discovery, Inc., is a pre-clinical stage biotechnology company with a cutting-edge computation driven discovery platform, and a focus on developing small molecule drug candidates for oncology and inflammatory conditions. Modulus runs a portfolio of ~10 discovery programs and has developed to date 3 highly sought-after clinical candidate molecules for neutrophil / mast-cell driven inflammatory conditions, and cancers
exhibiting DNA-damage repair deficiencies.
exhibiting DNA-damage repair deficiencies.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
MA
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Oncology
Lead Product in Development:
MOD-A for neutrophil-driven inflammation (Development Candidate Nominated); MOD-B for mast cell-driven inflammation (Under Profiling); MOD-C for precision oncology (Under Profiling)
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
